ChengDu ShengNuo Biotec (688117.SS) Earnings Analysis

ChengDu ShengNuo Biotec (688117.SS) has no confirmed upcoming earnings date. Trailing P/E 19.97.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 688117.SS next report earnings?

No confirmed upcoming earnings date is currently scheduled for 688117.SS. This page updates as the calendar is published.

688117.SS earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-04-240.42 CNYn/an/an/a
2026-02-270.24 CNYn/an/an/a
2025-08-150.27 CNYn/an/an/a
2025-04-250.3 CNYn/an/an/a
2025-02-28-0.0451 CNYn/an/an/a

688117.SS valuation and analyst view

Trailing P/E19.97
Trailing EPS1.171 CNY
Price / book3.28
Dividend yield1.47%
Market cap5.29B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is ChengDu ShengNuo Biotec (688117.SS)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for 688117.SS. This page updates as the calendar is published.

Did 688117.SS beat earnings last quarter?

Consensus estimate data was not available for 688117.SS's 2026-04-24 report.

What is 688117.SS's current P/E ratio and EPS?

688117.SS trades at a trailing P/E of 19.97 on trailing EPS of 1.1712670350914016 CNY.

What do analysts rate 688117.SS?

688117.SS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.